Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2972-52-3

Post Buying Request

2972-52-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2972-52-3 Usage

General Description

2,4-Dichloro-5-pyrimidinecarbonyl chloride is a chemical compound with the molecular formula C5H2Cl2N2O. It is a colorless to light yellow liquid at room temperature and is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 2,4-Dichloro-5-pyrimidinecarbonyl chloride is a derivative of pyrimidine and is also known by its chemical name 2,4-dichloro-5-chlorocarbonylpyrimidine. It is a versatile building block in organic synthesis and is commonly used as a reagent in the preparation of various pharmaceutical and agrochemical products. 2,4-Dichloro-5-pyrimidinecarbonyl chloride is considered to be hazardous if not handled properly and should be used with caution in a controlled laboratory environment.

Check Digit Verification of cas no

The CAS Registry Mumber 2972-52-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,9,7 and 2 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2972-52:
(6*2)+(5*9)+(4*7)+(3*2)+(2*5)+(1*2)=103
103 % 10 = 3
So 2972-52-3 is a valid CAS Registry Number.
InChI:InChI=1/C5HCl3N2O/c6-3-2(4(7)11)1-9-5(8)10-3/h1H

2972-52-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (728772)  2,4-Dichloropyrimidine-5-carbonyl chloride  97%

  • 2972-52-3

  • 728772-500MG

  • 1,102.14CNY

  • Detail

2972-52-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-Dichloropyrimidine-5-carbonyl chloride

1.2 Other means of identification

Product number -
Other names 2,4-Dichloro-5-pyrimidinecarbonyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2972-52-3 SDS

2972-52-3Relevant articles and documents

Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents

Liu, Lingfeng,Kong, Chengcheng,Fumagalli, Marco,Savková, Karin,Xu, Yiwen,Huszár, Stanislav,Sammartino, José C.,Fan, Dongguang,Chiarelli, Laurent R.,Miku?ová, Katarína,Sun, Zhaogang,Qiao, Chunhua

, (2020)

Decaprenylphosphoryl-β-D-ribose 2′-oxidoreductase (DprE1) is a promising drug target for the development of novel anti-tubercular agents, and inhibitors of DprE1 are being investigated extensively. Among them, the 1,3-benzothiazinone compounds such as BTZ

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

-

Paragraph 001035, (2021/02/19)

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

JNK inhibitor as well as pharmaceutical composition and application thereof

-

Paragraph 0406-0409; 0428-0431, (2021/03/31)

The invention provides a compound represented by a formula (I), racemates, stereoisomers, tautomers, isotope markers, solvates, polymorphic substances, nitrogen oxides, or pharmaceutically acceptablesalts thereof, and application as a JNK inhibitor. The invention also provides a preparation method of the compound shown in the formula (I), a pharmaceutical composition containing the compound shownin the formula (I), and application of the compound shown in the formula (I) to preparation of a medicine, and the medicine is used for treating diseases which can be treated by inhibiting the activity of JNK.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2972-52-3